COMPOSITION OF STEM CELLS HAVING HIGHLY EXPRESSED FAS LIGAND

摘要

This disclosure relates in general to a stem cell treatment. This disclosure further relates to a stem cell treatment using a composition comprising stem cells having highly expressed Fas-L. This disclosure further relates to a stem cell treatment of multiple myeloma. This disclosure also relates to a composition comprising stem cells having highly expressed Fas-L. This disclosure also relates to preparation of a composition comprising stem cell having highly expressed Fas-L. This disclosure also relates to preparation of a composition comprising stem cells having highly expressed Fas-L by using a salicylate. An example of salicylate may be aspirin. This disclosure further relates to a stem cell treatment of multiple myeloma. This disclosure also relates to a stem cell treatment of an inflammatory disease and/or autoimmune disease.

主权项

1. A method of preparing a composition suitable for a stem cell treatment of a mammal, wherein the preparation method comprises:
a. obtaining a tissue comprising a stem cell, b. treating the tissue to activate or increase level of Fas-L expression, and thereby obtaining a treated stem cell having highly expressed Fas-L, and c. preparing a composition comprising the treated stem cell having highly expressed Fas-L.